Want to see ANAB full AI Analyst Report?
AnaptysBio (ANAB) Income Statement
AnaptysBio Income Statement
Last quarter (Q2 2026), AnaptysBio's total revenue was $27.49M, an increase of 23.47% from the same quarter last year. In Q2, AnaptysBio's net income was $183.88M. See AnaptysBio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 234.60M | $ 91.28M | $ 17.16M | $ 10.29M | $ 63.17M | |
| $ 232.18M | $ -72.56M | $ -115.13M | $ -78.51M | $ -35.32M | |
| $ 184.28M | $ 42.39M | $ 49.28M | $ 36.64M | $ 21.49M | |
| Depreciation and Amortization | $ 2.42M | $ 2.40M | $ 2.38M | $ 2.33M | $ 2.09M |
| $ 69.25M | $ -92.74M | $ -154.70M | $ -105.26M | $ -55.71M | |
| $ 47.90M | $ -114.95M | $ -164.41M | $ -115.15M | $ -56.81M | |
| $ -60.96M | $ -30.28M | $ 788.00K | $ -13.55M | $ -982.00K | |
| $ -13.07M | $ -145.23M | $ -163.62M | $ -128.70M | $ -57.80M | |
| $ -13.23M | $ -145.23M | $ -163.62M | $ -128.72M | $ -57.80M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.46 | $ -5.12 | $ -6.08 | $ -4.57 | $ -2.11 |
| Diluted EPS | $ -0.46 | $ -5.12 | $ -6.08 | $ -4.57 | $ -2.11 |
| Weighted Average Shares Outstanding | 27.79M | 28.38M | 26.92M | 28.16M | 27.43M |
| Weighted Average Shares Outstanding (Diluted) | 31.34M | 28.38M | 26.92M | 28.16M | 27.43M |
Currency in USD